Sunteți pe pagina 1din 12

Joint Non-Lethal Weapons Program Overview

Non-Lethal Weapons Research & Technology Development Industry Day Col Tracy Tafolla Director, Joint Non-Lethal Weapons Directorate 22 June 2012

Col Tracy J. Tafolla


United States Marine Corps

Director

Distribution Statement A: Approved for public release; Distribution is unlimited

http://jnlwp.defense.gov

Joint Non-Lethal Weapons Directorate


3097 Range Road Quantico, Virginia 22134 http://jnlwp.defense.gov Telephone: DSN 278 or (703) 7841977 FAX: DSN 278 or (703) 784-3178 Classified FAX: DSN 278-9896 tracy.tafolla@usmc.mil

Department of Defense (DoD) Non-Lethal Weapons (NLW) Program


Established in 1996 with the Commandant of the Marine Corps as the DoD NLW Executive Agent The Joint Non-Lethal Weapons Directorate serves as the Executive Agents day to day management office, coordinating activities with the Services, Coast Guard, and other government agencies

General James F. Amos Commandant of the U.S. Marine Corps

The Executive Agent has a research budget dedicated to developing and advancing the suite of non-lethal weapons available to U.S. forces The military Services (Army, Air Force, Navy, Marine Corps) are responsible for NLW procurement and sustainment

Non-lethal effects are part of the Department of Defense portfolio of capabilities that enhance the Joint Force Commanders ability to act in a timely manner to detect, deter, prevent, defeat, or, if necessary, mitigate effects of an attack. General James F. Amos
Distribution A: Approved for public release; distribution unlimited 2

DoD NLW Program Management Structure


Dr Miller USD(P)
Policy Oversight

Mr Kendall USD(AT&L)
Principal Oversight

General Amos

DoD Non-Lethal Weapons Program

DoD NLW Program Executive Agent

CMC

Joint Non-Lethal Weapons Program


Col Tracy Tafolla
Chairman, JNLW Integrated Product Team (DC PP&O)

LtGen Tryon

Joint Non-Lethal Weapons Directorate

Service-Unique
Non-Lethal Weapons

Programs

Joint S&T

Joint R&D

Service S&T

Service RDT&E

Service
Procurement

Service O&M

Direct Oversight

Coordination

Distribution A: Approved for public release; distribution unlimited

Joint Non-Lethal Weapons Directorate


DIRECTOR
PRINCIPAL DEPUTY POLICY/& STRATEGY PRINCIPAL DEPUTY TECHNOLOGY TRANSITION AND INTEGRATION

STRATEGIC COMMUNICATION STRATEGIC COMMS OFF OFFICE

DEPUTY DIRECTOR

BUSINESS FINANCIAL MANAGEMENT OFFICE

ACQUISITION DIVISION

TECHNOLOGY DIVISION

CAPABILITIES & REQUIREMENTS DIVISION

OPERATIONS DIVISION

HEALTH EFFECTS OFFICE

JNLWD DESIGNATED AS JOINTLY MANNED ACTIVITY 18 NOVEMBER 1999

Distribution A: Approved for public release; distribution unlimited

JNLWP Budget
JNLWP
BA-4 ~ 45M/yr BA-3 ~ 11M/yr
BA-2: Applied Research (USN ONR/OSD Oversight) NL studies and analysis to augment and support current JNLWP areas of interest as well as explore new NLW technology opportunities: Includes experimentation and model development. (TRL 2&3) BA-3: Advanced Technology Development (USN ONR/OSD Oversight) Next generation NLW concepts and advanced prototype development to support challenging mission needs: Includes laboratory and field testing and model verification and validation. (TRL 4&5) BA-4: Advanced Component Development and Prototypes (ACD&P) (DC PP&O and ONR Oversight) Primary source of funds. Supports research and development of JNLWP efforts: includes efforts necessary to evaluate integrated technologies, prototype systems and to expedite technology transition from laboratory to operational use. (TRL 6&7)
Distribution A: Approved for public release; distribution unlimited 5

BA-2 ~ 6M/yr

DoD NLW Definition


Weapons that are explicitly designed and primarily employed so as to incapacitate personnel or materiel, while minimizing fatalities, permanent injury to personnel, and undesired damage to property and the environment.

Key Attributes: Incapacitation and Reversibility Representative Mission Applications


Humanitarian Assistance/Disaster Relief Vehicle/Vessel Stopping Clearing Structures/Facilities Check-Point /Convoy Security Crowd Control FOB/Facility Security Maritime Stability Operatoins Support to Civil Authorities Detainee Operations Counter Piracy

Distribution A: Approved for public release; distribution unlimited

Risk of Significant Injury (RSI)


RSI is a measure of reversibility Health care capability (HCC) indexes are used as the basis to determine RSI from NLW. RSI is considered for both counterForward Resuscitative and personnel and counter-material Theater Hospitalization technologies Capabilities: Advanced
RSI is measured as a weapons likelihood to cause injury resulting in HCC1 or HCC 2

Emergency, Surgical, and Ancillary Services

RSI is relevant to all NLW research and technology development efforts

1 0

First Responder Capability: Requiring Resuscitation, Stabilization, and Emergency Care Limited First Responder Capability (LFRC): Self-aid, Buddy Aid, and Combat Lifesaver Skills
7

Distribution A: Approved for public release; distribution unlimited

Fielded Non-Lethal Weapons


12 Gauge / 40 MM Point, Area and Warning Munitions FN303 Optical Distractors
Training Permanent Paint

Washable Paint

66mm Vehicle Launched NL Grenades TASER X26TM Modular Crowd Control Munitions Flash Bang Grenades

Portable Vehicle Arresting Barrier

Vehicle Lightweight Arresting Device M2 Net

Stingball Grenades & Launch Cups

Pen Flares

Acoustic Hailing Devices


8

Distribution A: Approved for public release; distribution unlimited

Joint Non-Lethal Weapons Program: Capability Focus Areas


Counter Personnel : Deny areas to individuals Move individuals Disable combatants Suppress combatants

Counter Material : Stop/disable vehicles Stop/disable vessels Stop/disable/divert aircraft Deny access to a facility

Distribution A: Approved for public release; distribution unlimited

Joint Non-Lethal Weapons Program: Technical Focus Areas


Non-Lethal Directed Energy Active Denial Technology Laser Technology Radio Frequency / High Power Microwaves (Counter-Electronics) Vehicle/Vessel Stopping Independent Technical Reviews Human Effects and Effectiveness Human Electromuscular Incapacitation Nanosecond Electrical Pulse Blunt Impact Technologies New/Advanced Non-Lethal Materials
Distribution A: Approved for public release; distribution unlimited 10

Non-Lethal Weapons Research and Technology Development Goals


Provide warfighters with additional escalation-of-force options while minimizing casualties and collateral damage Stimulate innovative solutions to the toughest non-lethal technology challenges Conduct the scientific research necessary to understand the risk of injury and build confidence in the effectiveness of emerging technology solutions Accelerate technology development to support the current fight and conduct science and technology research to help address uncertain future needs

Distribution A: Approved for public release; distribution unlimited

11

Questions?
http://jnlwp.defense.gov
wesley.burgei@usmc.mil alicia.owsiak@usmc.mil
12

Distribution A: Approved for public release; distribution unlimited

S-ar putea să vă placă și